| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 9JD9B4S53T |
| InChI Key | XCGJIFAKUZNNOR-QCKZDCLWSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H21ClF2O4S |
| Molecular Weight | 442.91 |
| AlogP | 5.34 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 71.44 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Aspartic protease
Aspartic protease AD clan
Aspartic protease A22A subfamily
Aspartic protease A22A regulatory subfamily
|
- | 5-55 | - | - | - | |
|
Enzyme
|
- | 5-55 | - | - | - | |
|
Ion channel
Other ion channel
Miscellaneous ion channel
Presenilin ER Ca2+ leak channel family
|
- | 5-55 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 471905-41-6 |
| ChEMBL | CHEMBL4205422 |
| DrugBank | DB12852 |
| FDA SRS | 9JD9B4S53T |
| PubChem | 9803433 |
| SureChEMBL | SCHEMBL756247 |
| ZINC | ZINC000100015572 |